Etoposide
A. Cell-cycle nonspecific, inhibitor of tyrosine kinase activity
B. Cell cycle specific, inhibitor of microtubule assembly
C. Cell-cycle specific, inhibitor of topoisomerase activity
D. Cell-cycle non-specific, cardiotoxicity a possible side effect
Answer: C. Cell-cycle specific, inhibitor of topoisomerase activity
You might also like to view...
Which factor should be examined FIRST when the LP/VN is establishing priorities of care for a client?
a. To whom can certain tasks be assigned? b. Has the client previously been assigned to be cared for by unlicensed assistive personnel? c. What is the client's current health care status? d. Has the client been hospitalized before?
The nurse assesses a client who has recently developed nausea and vomiting, blurred vision, and palpitations.The history reveals that the client recently increased the dosage of digoxin
Which of the following age-related changes are most likely related to these symptoms? A) Cerebral cortex changes causing flu-like symptoms B) Heart changes that are affecting the ability to ingest the digoxin C) Age-related changes in cortical control of micturition D) Kidney changes that affect elimination of the digoxin
While assessing a 10-month-old African American infant, the nurse notices that the sclerae have a yellowish tint. Which organ system should the nurse further evaluate to determine an ongoing disease process?
1. Cardiac 2. Respiratory 3. Gastrointestinal 4. Genitourinary
A pregnant patient is treated with trimethoprim/sulfamethoxazole (TMP/SMZ) (Bactrim) for a urinary tract infection at 34 weeks' gestation. A week later, the woman delivers her infant prematurely. The nurse will expect to monitor the infant for:
a. birth defects. b. hypoglycemia. c. rash. d. scleral jaundice.